Ticker LaunchIPO · DYN
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. (DYN) priced its initial public offering on Sep 17, 2020 at $19.00 per share, above its $16.00–$18.00 range, raising $232.8M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $828.1M. WilmerHale advised the company and Cooley advised the underwriters.
- Status
- IPO
- Ticker
- DYN
- Exchange
- Nasdaq Global Select
- Priced
- Sep 17, 2020
- IPO price
- $19.00
- Price range
- $16.00–$18.00
- Raised
- $232.8M
- Market cap at IPO price
- $828.1M
- First filed
- Aug 25, 2020
- Company counsel
- WilmerHale
- Underwriters' counsel
- Cooley
- Sector
- Biotech & pharma
- Country / state
- MA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Aug 25, 2020
- Latest amendment Sep 10, 2020
- Final prospectus (424B4) Sep 17, 2020
- All filings on EDGAR CIK 1818794
Other Biotech & pharma IPOs in 2020
- CalciMedica, Inc.GRAY · Sep 25, 2020 · $90M
- PMV Pharmaceuticals, Inc.PMVP · Sep 25, 2020 · $211.8M
- Prelude Therapeutics IncPRLD · Sep 25, 2020 · $158.2M
- COMPASS Pathways plcCMPS · Sep 21, 2020 · $127.5M
- LeonaBio, Inc.ATHA · Sep 18, 2020 · $204M
- Metacrine, Inc.MTCR · Sep 16, 2020 · $85M